We agree in general with Malhi et al's forthright Editorial "Make Lithium Great Again", where they reiterate that, despite its clear efficacy and effectiveness, lithium remains under-utilised in the treatment of bipolar disorder. Possible reasons they give for this include prescription of second generation antipsychotics (SGAs), which may appear easier to prescribe, are marketed better, and may appear to require less monitoring.

Original languageEnglish
JournalBipolar Disorders
Early online date26 Sept 2020
Publication statusE-pub ahead of print - 26 Sept 2020


Dive into the research topics of 'Back to basics- a UK perspective on "Make lithium great again" Malhi et al'. Together they form a unique fingerprint.

Cite this